NCT00171106View on ClinicalTrials.gov

Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure

PHASE4CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

August 31, 2007

Study Completion Date

February 29, 2008

Conditions

Diastolic Dysfunction, Symptomatic Heart Failure

Interventions

DRUG

valsartan

Trial Locations (2)

Unknown

Investigative Centers

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY